3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Conditions
Multiple Myeloma
3
Lymphoma, Non-Hodgkin
3
Sezary Syndrome
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Hairy Cell
2
Burkitt Lymphoma
2
Waldenstrom Macroglobulinemia
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Paraproteinemias
1
Myeloproliferative Disorders
1
Lymphoproliferative Disorders
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Large Granular Lymphocytic
1
Immunoblastic Lymphadenopathy
1
Hodgkin Disease
1
Interventions
plerixafor
1
Specimen Handling
1
Radiotherapy
1
Oxycodone
1
Ondansetron
1
Music Therapy
1
Morphine
1
Methadone
1
Granulocyte Colony-Stimulating Factor
1
Genetic Testing
1
Genetic Counseling
1
Follow-Up Studies
1
Fluorescent Antibody Technique
1
Chromatin Immunoprecipitation Sequencing
1
Aprepitant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Lymphoproliferative Disorders
×
plerixafor
×
Clear all
NCT01186224
2025-03-17
PHANTASTIC
University of Liverpool
Phase NA
Completed
60 enrolled